CB(2) Receptor Agonists Protect Human Dopaminergic Neurons against Damage from HIV-1 gp120

Despite the therapeutic impact of anti-retroviral therapy, HIV-1-associated neurocognitive disorder (HAND) remains a serious threat to AIDS patients, and there currently remains no specific therapy for the neurological manifestations of HIV-1. Recent work suggests that the nigrostriatal dopaminergic...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Shuxian, Sheng, Wen S., Rock, R. Bryan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798286/
https://www.ncbi.nlm.nih.gov/pubmed/24147028
http://dx.doi.org/10.1371/journal.pone.0077577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798286/
https://www.ncbi.nlm.nih.gov/pubmed/24147028
http://dx.doi.org/10.1371/journal.pone.0077577

Ejemplares similares